Pittsburgh, PA
April 10-11, 2026

Two Days. One Mission. Transforming Precision Cancer Care.

Pittsburgh, PA
April 10-11, 2026

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Pittsburgh

Where translational science meets compassionate care
Pittsburgh’s strong foundation in research and clinical innovation makes it the ideal setting to connect pathology and oncology expertise. This free, CME-accredited conference highlights new approaches in molecular testing, AI-driven diagnostics, and biomarker-guided therapies—empowering physicians to bring the latest advances directly to their patients.

Agenda

Registration Coming Soon!

April 10, 2026
8:00 AM	Registration & Check-in
8:50 AM	Welcome and Introductions
9:00 AM	Breast Cancer: Biomarkers & Methodologies
9:30 AM	Breast Cancer
10:00 AM	Exhibits/Breakfast
10:30 AM	Non-CME Session
11:15 AM	Exhibits/Break
11:45 AM	Lung Cancer: Biomarkers and Methodologies
12:15 PM	Lung Cancer
12:45 PM	Colorectal Cancer: Biomarkers & Methodologies
1:15 PM	Colorectal Cancer
1:45 PM	Exhibits/Lunch
2:15 PM	Non-CME Session
2:45 PM	Exhibits/Break
3:15 PM	Digital Pathology
3:45 PM	Liquid Biopsy
4:15 PM	Closing Remarks

Learning Objectives

Integrate evidence-based advances from both pathology and oncology to enhance biomarker testing, diagnosis, and treatment planning for solid tumors and hematologic malignancies.
Apply multidisciplinary insights and new clinical data to improve therapeutic decision-making and patient outcomes across diverse practice settings.

Accreditation Information | TBD CE/CME Credits

Additional Information Coming Soon

April 11, 2026
8:00 AM	Registration & Check-in
8:25 AM	Welcome and Introductions
8:30 AM	Ovarian Cancer: Biomarkers & Methodologies
9:00 AM	Ovarian Cancer
9:30 AM	Breakfast/Exhibits
10:00 AM	Non-CME Session
10:45 AM	Break/Exhibits
11:15 AM	Hemapathology
11:45 PM	Myeloma
12:15 PM	Leukemia
12:45 PM	Lunch/Exhibits
1:15 PM	Non-CME Session
2:00 PM	Break/Exhibits
2:30 PM	Prostate Cancer: Biomarkers & Methodologies
3:00 PM	Prostate Cancer
3:30 PM	Precision Oncology
4:00 PM	Closing Comments

Speakers

CHAIR
Marija Balic
Chief of Medical Breast Oncology
UPMC Magee Women's Hospital
View Profile
Professor
Department of Medicine, Division of Hematology/Oncology
UPMC
Professor of Medicine, UPMC
Chief of Medical Breast Oncology, UPMC Magee Women's Hospital
Co-director of Magee Womens Cancer Program
Clinical Co Leader of the Womens Cancer Research Program
Marija Balic MD, PhD, is Professor of Medicine at the University of Pittsburgh School of Medicine. She serves Co-Director of Women’s Cancer Program at the UPMC Magee Women’s Hospital, Pittsburgh, PA. and Clinical Co- Leader of Women’s Cancer Research Center (WCRC).
Dr. Balic has joined University of Pittsburgh from the Medical University of Graz, where she was Deputy Head of the Department of Oncology, head of the interdisciplinary breast center, head of research unit for translational breast cancer research, head of the clinical trial unit in the Department of Oncology, lead coordinator for clinical studies in the Department of Internal Medicine, and program director for breast cancer.
She is a prolific member of the breast cancer research community with several ongoing projects with funding, over 100 publications, mentorship of graduate students, numerous presentations at scientific symposia and conferences around the globe, and service to committees and boards.
Dr. Balic earned her MD from the Karl-Franzens University of Graz, School of Medicine and her Dr. Sci. Med and MBA from the Medical University of Graz in Austria.